Search result

Phantom 4 RTK/feed/category/dji-mavic-3e-pl- Page 176

Nextracker Rebrands as Nextpower: NXT Stock Slips as Company Unveils Power‑Conversion Push and Long‑Term Targets (Nov. 12, 2025)

Nextracker Rebrands as Nextpower: NXT Stock Slips as Company Unveils Power‑Conversion Push and Long‑Term Targets (Nov. 12, 2025)

FREMONT, Calif. — November 12, 2025. Solar‑tracker leader Nextracker Inc. has rebranded as Nextpower Inc., signaling a broader pivot from single components to a fully integrated energy‑technology platform. The move arrives alongside fresh long‑term targets and the launch of a power‑conversion systems (PCS) line slated to begin shipping in 2026. The Nasdaq ticker remains NXT. Business Wire Key takeaways What changed: from Nextracker to Nextpower Management says the new brand captures the company’s evolution “into a full‑platform provider” that connects hardware, software, and services across the design, build, and operate lifecycle of modern power plants. “Our customers want coherent, integrated
Nuvve Holding (NVVE) Soars on Japan Storage Deal as Q3 2025 Earnings Loom

Nuvve Holding (NVVE) Soars on Japan Storage Deal as Q3 2025 Earnings Loom

NVVE stock today: violent spike after Japanese storage deal As of the latest official close, Nuvve Holding Corp. shares were at about $0.1562 on Nasdaq, down roughly 2% on the day. But that closing price doesn’t tell the story of what happened next. Even after this spike, NVVE is still down about 95% over the past year, with a 52‑week range of roughly $0.15 to $5.02. Benzinga+1 Given the thin float, tiny market cap and heavy headline trading, NVVE is behaving like a high‑risk, high‑volatility micro‑cap, where single press releases can drive triple‑digit percentage moves in a single session. The
13 listopada 2025
Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson has struck a $3.05 billion cash deal to acquire Halda Therapeutics, a privately held cancer-drug developer based in New Haven, Connecticut, in one of 2025’s biggest oncology takeovers so far.Reuters+1 The move deepens J&J’s bet on cancer medicines just as sales of its long‑time blockbuster psoriasis drug Stelara are being hit hard by a wave of cheaper biosimilar rivals.Yahoo Finance+1 Key points Inside Johnson & Johnson’s Halda Therapeutics takeover J&J said on Monday that it will acquire Halda Therapeutics for $3.05 billion in cash, adding a new set of precision oncology assets to its Innovative Medicine unit.Reuters+1
Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder, Inc. (ASX: LNW, formerly NASDAQ: LNW) has hit a turning point this week. As of 17 November 2025, the cross‑platform gaming group has fully completed its move to a sole listing on the Australian Securities Exchange (ASX), shifted its US$1.5 billion share buyback onto the Australian market, and attracted fresh attention from both institutional investors and brokers. AGB Today’s key Light & Wonder headlines (17 November 2025) ASX‑only listing now in effect Light & Wonder has spent months preparing to exit Nasdaq and concentrate trading on the ASX. The company first notified Nasdaq of its intention to
17 listopada 2025
Compass-Backed Lugano Diamonds Files for Chapter 11 Bankruptcy Amid Fraud Allegations and Luxury Retail Slowdown

Compass-Backed Lugano Diamonds Files for Chapter 11 Bankruptcy Amid Fraud Allegations and Luxury Retail Slowdown

November 18, 2025 Lugano Diamonds & Jewelry Inc., the ultra-luxury jeweler known for multimillion‑dollar bespoke pieces and private salons, has filed for Chapter 11 bankruptcy in Delaware and put itself up for sale, just as the crucial holiday shopping season kicks into gear. The Newport Beach–based retailer, majority‑owned by investment firm Compass Diversified, is seeking court protection after internal probes uncovered serious financial irregularities and a cascade of lawsuits tied to its former chief executive and co‑founder, Mordechai “Moti” Ferder. JCK At the same time, the move underscores how even the very top of the luxury market is feeling the
18 listopada 2025
Amer Sports (AS) Jumps After Q3 2025 Earnings Beat and Raised Outlook as Salomon & Arc’teryx Power 30% Sales Surge

Amer Sports (AS) Jumps After Q3 2025 Earnings Beat and Raised Outlook as Salomon & Arc’teryx Power 30% Sales Surge

Amer Sports, the Finnish parent of premium outdoor and sports brands like Arc’teryx, Salomon and Wilson, delivered a blockbuster third quarter on Tuesday, beating Wall Street expectations, raising full‑year 2025 guidance for the second time this year and sending its stock sharply higher. investors.amersports.com+2amersports.com+2 Key takeaways from Amer Sports’ Q3 2025 report Q3 2025: 30% revenue growth and a clean beat Amer Sports’ official release described Q3 2025 as a period of “strong momentum” as the company’s portfolio of premium technical brands gained share in sports and outdoor markets globally. investors.amersports.com+2Stock Titan+2 For the quarter ended 30 September 2025, Amer
18 listopada 2025
Crypto Market Carnage: Bitcoin Crashes from Record Highs as Tariff Bombshell Wipes Out $20B

Bitcoin Price Forecast 2025–2026: Post-Halving Rally or Correction? Latest Insights and Predictions

Bitcoin Eyes Year-End and 2026 Outlook: As of mid-November 2025, Bitcoin (BTC) is trading around $93,000 after a volatile year that saw new all-time highs and a sharp pullbackcoingape.comcoingape.com. Investors are now weighing short-term price drivers against long-term forecasts, with experts divided on whether the leading cryptocurrency will reignite a post-halving bull run or face further consolidation going into 2026. In this report, we’ll examine the latest news impacting BTC, Q4 2025 predictions, and 2026 forecasts from analysts and institutions, along with key factors like market sentiment, macroeconomic forces, upcoming regulations/ETFs, the 2024 halving effect, technical trends, and the risks and opportunities ahead. Bitcoin at a Crossroads in Late 2025 (Latest Market Update) Bitcoin’s price surged to
Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Published November 19, 2025 Target (NYSE: TGT) is heading into the critical holiday shopping season under intense pressure after reporting another quarter of declining sales, trimming its profit outlook and unveiling an ambitious turnaround plan built around price cuts, store upgrades and new AI partnerships — including a shopping app inside ChatGPT. Q3 2025 earnings: sales slip, profit holds up Target’s third‑quarter fiscal 2025 numbers show a retailer still stuck in reverse on sales, but squeezing enough efficiency out of the business to beat Wall Street’s profit expectations. According to Target’s earnings release and filings: The top line was weak,
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price on 19 November 2025 As of late Wednesday trading, Boston Scientific stock was changing hands at around $96.6, down roughly 2.6% on the day. Intraday, BSX has traded in a range of roughly $96–$100, with volume running in the high single‑digit millions of shares.Investing.com Recent price action shows a short losing streak: BSX closed at about $99.2 on Tuesday (‑2.5%),
19 listopada 2025
Target Shocks Workers: 1,000 HQ Jobs Cut Before Christmas – Retail Giant’s Woes Deepen

Target (TGT) Q3 2025 Earnings: EPS Beat, Sales Miss and Holiday Price War Weigh on the Stock

Target Corporation (NYSE: TGT) reported third‑quarter 2025 results today, November 19, posting better‑than‑expected earnings per share but another decline in sales as cautious U.S. shoppers traded down and pulled back on discretionary purchases. Revenue came in slightly below Wall Street forecasts, and shares fell in response, even as management rolled out aggressive holiday discounts and a larger investment plan to revive growth. Target Corporation+2Reuters+2 As of early afternoon U.S. trading, TGT stock was hovering in the mid‑$80s, down roughly 2–3% on the day, after dropping more than 3% in pre‑market trading following the release. Investing.com+1 Target Q3 2025 Earnings at a Glance
19 listopada 2025
Nvidia’s Meteoric October: $4 Trillion Milestone, Mega AI Deals, and Unstoppable Momentum

Nvidia Q3 2026 Earnings: Record $57 Billion Revenue as AI Chip Demand Supercharges Data Center Business

Published: November 19, 2025 Nvidia has once again rewritten the record books. On Wednesday, the AI chip leader reported third-quarter fiscal 2026 results that smashed Wall Street expectations, powered by soaring demand for its data center GPUs used to train and run artificial intelligence models. Revenue hit a record $57.0 billion, up 22% quarter over quarter and 62% year over year, with profit and guidance both coming in ahead of forecasts.NVIDIA Newsroom+1 After the report, Nvidia shares jumped in after-hours trading, adding to a rally into the close as investors cheered another blowout AI quarter.Kiplinger Key Numbers From Nvidia’s Q3 FY2026 For the fiscal quarter
NVIDIA’s Stock Soars to New Highs – Analysts Eye Further Gains

Nvidia Stock Today (NVDA) on November 19, 2025: Shares Jump After Record $57 Billion Q3 Revenue and Bullish AI Outlook

Published: November 19, 2025 Nvidia stock took center stage on Wall Street today as the AI chip giant delivered another blockbuster earnings report and signaled that demand for its GPUs is still accelerating, not cooling. After a volatile few weeks marked by talk of an “AI bubble,” Nvidia’s results for its fiscal third quarter of 2026 and its strong outlook helped push NVDA higher in both regular and after-hours trading, while calming broader market jitters. ABC17NEWS+1 Nvidia stock price today: how NVDA traded on November 19, 2025 During Wednesday’s regular session, Nvidia (NASDAQ: NVDA) gained just under 3%, closing at $186.52. The
20 listopada 2025
MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre, Inc. (NASDAQ: MELI) is back in the spotlight today, 20 November 2025, as its share price slides sharply even while new filings show fresh institutional buying and a recently filed mixed shelf registration reshapes expectations for the Latin American e‑commerce giant’s next growth phase. Below is a breakdown of the key MercadoLibre news and market action specifically dated 20 November 2025, plus the broader context investors are watching. MercadoLibre stock on 20 November 2025: Pullback deepens near support After a strong multi‑year run, MELI stock is decisively on the back foot today. According to MarketScreener’s Nasdaq data, MercadoLibre shares
20 listopada 2025
Coca-Cola (KO) Stock: 7 Surprising Facts You Need to Know (Oct 11, 2025)

Coca-Cola Stock (KO) Today: Price, Fresh Analyst Calls and Key News on November 21, 2025

Published: November 21, 2025 – All figures as of market trading on this date. Coca-Cola stock today: near highs with fresh momentum Coca-Cola stock (NYSE: KO) is trading around $73 per share in Friday’s session, up roughly 2–2.5% from Thursday’s close of $71.21.StockAnalysis+1 That puts the beverage giant within touching distance of its 52‑week high of $74.38, and well above its 12‑month low of $60.62.StockAnalysis+1 Over the last year, Coca-Cola has delivered about 15% total shareholder return, including dividends, and is up just over 15% year to date, underscoring its role as a defensive winner in a choppy market.Simply Wall
21 listopada 2025
Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk stock is back in the spotlight today, 21 November 2025, as a cluster of breaking headlines hits the world’s most closely watched weight‑loss drug maker. As of late morning in New York, Novo Nordisk’s U.S. ADR (NYSE: NVO) is trading around $47.07, down roughly 1.1% on the day, giving the company a market value close to $213 billion. In Copenhagen, Novo Nordisk’s B‑shares finished the session around DKK 305, down nearly 3% and extending a steep slide that has left the stock down about 45% year‑to‑date. Investing.com+1 Today’s trading comes against a flurry of fresh news: Below is
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics stock is one of those tickers that still pops up on certain quote screens in late 2025 – but in reality, it isn’t a “normal” stock anymore. As of Sunday, November 23, 2025, NeuBase is a dissolved biotech in legal wind‑down, its common shares delisted and largely cashed out through liquidation payments and a non‑tradable escrow structure. MarketWatch+1 Below is a deep, investor‑focused look at what NBSE actually represents today, what happened in 2024–2025, and what, if anything, existing shareholders can still reasonably expect. Key takeaways for NBSE on November 23, 2025 Where NeuBase stands today (Sunday, November
23 listopada 2025
1 174 175 176

Stock Market Today

Go toTop